Clinical Trial Update: Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance [Phase 2]

View source ↗

Summary

Phase 2 trial comparing standard-dose versus adjusted-dose lopinavir/ritonavir in HIV-infected individuals with drug resistance has completed. No detailed resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED